{"_buckets": {"deposit": "b3fcb438-57f7-43c2-af79-de84350579e8"}, "_deposit": {"id": "16449", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "16449"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:00016449", "sets": ["1504"]}, "item_9_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2013-08", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3-4", "bibliographicPageEnd": "179", "bibliographicPageStart": "169", "bibliographicVolumeNumber": "75", "bibliographic_titles": [{"bibliographic_title": "Nagoya Journal of Medical Science"}]}]}, "item_9_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Ubiquitous Epstein-Barr virus (EBV) infects not only B cells but also T and NK cells, and is associated with various lymphoid malignancies. The spectrum of EBV-associated lymphoid malignancies is expanding from Burkitt lymphoma to the newly defined systemic EBV+ T cell lymphoproliferative disease of childhood and hydroa vacciniforme-like lymphoma. However, some EBV-associated malignancies are not defined well and overlap other diseases. Furthermore, the role of EBV in tumorigenesis of lymphoid malignancies is still not clear. Further studies are necessary to clarify the pathogenesis of EBV-associated lymphoid malignancies for a better classification of each disease and for the establishment of effective treatment.", "subitem_description_type": "Abstract"}]}, "item_9_identifier_60": {"attribute_name": "URI", "attribute_value_mlt": [{"subitem_identifier_type": "URI", "subitem_identifier_uri": "http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/7534/7534.html"}, {"subitem_identifier_type": "HDL", "subitem_identifier_uri": "http://hdl.handle.net/2237/18466"}]}, "item_9_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.18999/nagjms.75.3-4.169", "subitem_identifier_reg_type": "JaLC"}]}, "item_9_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Nagoya University School of Medicine"}]}, "item_9_select_15": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_9_source_id_7": {"attribute_name": "ISSN（print）", "attribute_value_mlt": [{"subitem_source_identifier": "0027-7622", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kimura, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "49202", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kawada, Jun-ichi"}], "nameIdentifiers": [{"nameIdentifier": "49203", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ito, Yoshinori"}], "nameIdentifiers": [{"nameIdentifier": "49204", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-02-20"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "02_Kimura.pdf", "filesize": [{"value": "349.8 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 349800.0, "url": {"label": "02_Kimura.pdf", "url": "https://nagoya.repo.nii.ac.jp/record/16449/files/02_Kimura.pdf"}, "version_id": "87c6e03c-c750-4049-81c4-b38811a309da"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "EBV", "subitem_subject_scheme": "Other"}, {"subitem_subject": "latency", "subitem_subject_scheme": "Other"}, {"subitem_subject": "systemic EBV^+ T cell lymphoproliferative disease of childhood", "subitem_subject_scheme": "Other"}, {"subitem_subject": "hydroa vacciniforme-like lymphoma", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES : THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES : THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS"}]}, "item_type_id": "9", "owner": "1", "path": ["1504"], "permalink_uri": "https://doi.org/10.18999/nagjms.75.3-4.169", "pubdate": {"attribute_name": "公開日", "attribute_value": "2013-09-11"}, "publish_date": "2013-09-11", "publish_status": "0", "recid": "16449", "relation": {}, "relation_version_is_last": true, "title": ["EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES : THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS"], "weko_shared_id": null}